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hool of Pharmacy, UnivSummary Specific targeting of patients with a previous asthma hospitalisation
could be more focused if predictors could be identified. This study was an
observational retrospective analysis using ridge and linear multivariate regression
analysis. Patient asthma management data were extracted from the hospital and
general practice notes of those that had been admitted with an acute exacerbation
of their asthma over a 5-year period. From the prescribing data, the annual doses of
preventer (P) and reliever (R) medication were converted to defined daily doses then
divided to give a P:R ratio. Preliminary statistical analysis was used to identify any
association between either the P:R ratio or for the number of general practitioner
(GP) practice appointments (PA) and their asthma management data. Multivariate
regression analysis was applied to the P:R ratio and to PA to determine a model
between each of these and asthma management data/events. GPs gave consent to
access the data of 115 (out of 440) asthmatics, age45 years, admitted to a district
general hospital for asthma exacerbations between 1994 and 1998. The multivariate
analysis revealed that PA was associated with oral prednisolone rescue courses
(PRCs) and age whilst the P:R ratio was associated to PRCs and more reliever usageElsevier Ltd. All rights reserved.
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J. Salamzadeh et al.736but not preventers. Patients with low preventer usage with respect to their reliever
medication should be targeted for medication review as these were the patients
prescribed more prednisolone courses and their increased PAs reflect this. This could
decrease visits to the doctor and acute exacerbations.
& 2004 Elsevier Ltd. All rights reserved.Introduction
The management of asthma within primary care is a
considerable burden on the health care services.
According to a report published in 1999, almost
£672 million was spent on asthma in 1995/96 (£723
million inflated to 1997/1998 levels), with 91%
(£614 million) in primary care. Of this primary care
spend, 91% (£557 million) was for prescribed
asthma medicines and 9% (£57 million) for GP
consultations. The estimated number of primary
care consultations due to asthma in the same
period of time (1995/1996) was about six million
and the number of patients was approximately 2.5
million. This number of consultations included 2.6%
of the total GP consultations.1,2
In 1994, the Audit Commission presented the
ratio of inhaled corticosteroids (preventer—P) to
bronchodilators (reliever—R) ratio (P:R ratio) as an
indicator of the prescribing quality for asthma at
the general practice level.3 Although, using the P:R
ratio as an indicator of asthma prescribing quality
could have some drawbacks; for instance over-
prescribing of preventers could result in greater
ratios, it could be applied as a surrogate to assess
the quality of prescribing for asthma. It has been
shown that this ratio is an indicator of prescribing
quality for asthma at the practice level and an
important factor related to asthma morbidity.4
Several studies carried out within the secondary
care sector, have investigated relationships be-
tween asthma events/prescribing and demographic
or socio-economic characteristics of asthmatic
patients.5–21 They have also proposed to examine
the relationship between the P:R ratio and asthma
events in primary and secondary care.17,19-20,22–26
However, conclusive information about the asthma
care within primary sector and linking these data to
the secondary care information of individual asth-
matics has not been addressed.
A report published by the National Asthma and
Respiratory Training Centre27 recommends that
specific targeting of patients with a previous
asthma hospitalisation (high-risk group) could be
cost effective. This study was designed to identify
if there is any relationship within the asthma
management of these patients that could be
related to an acute admission. Each relationship,
from retrospective data collected from asthmaticpatients that had been admitted with an acute
exacerbation, has been described by building a
model, using a sophisticated analysis method called
‘‘ridge regression analysis’’.Method
A retrospective analysis of the primary and sec-
ondary care medical records data of asthma
patients (aged 45years) admitted to hospital
because of an acute exacerbation, during a 5-year
period has been completed. Patients whose med-
ical notes indicated the possibility of co-existing
chronic obstructive pulmonary disease or any other
chest problem were excluded. Local research
ethics committee approval was obtained and all
general practitioners (GPs) whose patients had
been admitted gave consent to access their
patient’s medical records. At the time of this study
for the collection of the retrospective data,
available between the years 1994 and 1998, the
Data Protection Act did not require patient consent
to access this information from their medical
records.
Data collection
Data collected from primary and secondary medical
records of each patient were age, sex, ethnicity
(South Asian or non-South Asian), history of allergy
and any history of eczema/hay fever. Information
about the number of practice appointments (PAs),
the number of home visits (HVs), the number of
prednisolone rescue courses per year (PRCs) and
the preventers and relievers prescribed by GPs
were also collected. Practice information with
respect to the Townsend Index (TI: an indicator of
material deprivation) and Jarman underprivileged
area score (JS: an indicator of potential workload
on GP’s services) for each patient was determined
from information obtained from the Manchester
Information and Associated Services, Census Dis-
semination Unit. The JS for practices and TI for
patients were assigned via their postal address.
The number of the PAs was used as a proxy of
health services utilisation in the primary care
sector and GP consultation rates for asthma. All
ARTICLE IN PRESS
Relationship between the quality of prescribing and practice appointment rates 737preventers and relievers that had been prescribed
for each patient per year were converted to
defined daily doses (DDDs) using the Anatomical
Therapeutic Chemical classification index with
DDDs.28 From these data, the P:R ratio was
calculated.Statistical analysis
The statistical package SPSS (version 10) was
used to perform the analysis. The analysis process
was performed in three main steps (preliminary
analysis, interaction evaluation and multivariate
analysis).
The distribution of the number of PAs/month and
P:R ratio were very skewed. It was found that a
square root transformation of PAs/month (OPA) and
a logarithmic transformation of P:R ratio (log P:R)
provided the most significant normal distribution,
confirmed by the Kolmogorov–Smirnov test. Pre-
liminary statistical analyses were used to identify
the predictors from the patient asthma data which
were highly likely associated with either the square
root of the PAs or log P:R ratio. The Mann–Whitney
test was used to analyse any association between
binary predictors, i.e. gender, allergy status,
history of hay fever/eczema, ethnicity (South Asian
and non-South Asian—mostly Caucasian), the TI
(affluent or deprived), the Jarman Score (low- or
high-workload GPs) with either the square root of
the PAs or the log P:R ratio data. Likewise, linear
regression analysis was used to test the possible
relationship between the continuous predictors,
i.e. age, the number of PRCs/year and the number
of HVs/month with either the square root of the PA
or the log P:R ratio.29 All associations with a Po0.2
were considered to be used in the multivariate
regression analysis.30
Further statistical analysis was carried out to
determine if there was any interaction between
any of the eligible predictors that had been
identified for the multivariate regression analysis.
This was done using the Mann–Whitney test, the
chi-square test and the Kendall’s rank correlation
analysis.29
For the multivariate regression analysis of
the PAs, due to significant interactions between
predictors, the ridge regression was applied
instead of the ordinary regression analysis to build
the final model. For the log P:R ratio, ordinal
multivariate regression analysis was applied to the
final model building. For both the multivariate
regression analyses, the significance level was
Po0:05:Results
There were 440 asthmatic patients admitted to the
Airedale General Hospital with an acute exacerba-
tion of their asthma during the 5-year study period.
One hundred and twenty-eight GPs managed the
health care of these 440 asthmatics. Thirty-three
(25.8%) of these GPs gave consent to access their
patients’ medical records in practices. These 33
consenting GPs managed 115 (26.1%) of the asth-
matic patients admitted to the hospital. Compar-
ison of the Jarman Scores and TI for the patients
managed by the consenting and non-consenting GPs
revealed no difference. Demographic and medical
details of these 115 patients are presented in
Table 1. There were 75 (65.2%) patients without
HVs and 54 (47%) patients without PRCs during the
study periodPractice appointments (PAs)
The mean (SD) and the median (interquartile range)
of PAs/month were 1.01(0.70) and 0.90
(0.47–1.41), respectively. The results of the pre-
liminary analyses to identify the eligible predictors
for entering into the multivariate analysis are
presented in Table 2. There were direct significant
relationships between the PRCs and age with the
OPAs. In addition, a borderline positive association
between theOPAs with the TI was observed, so that
patients from more deprived areas could have a
higher number of PAs. There also were non-
significant associations with a Po0:2 between the
OPAs and the Jarman score, ethnicity and allergy
status. Therefore, these six predictors (TI, JS,
ethnicity, allergy status, age and the number of
PRCs) were eligible to enter the multivariate
regression analysis. Two remaining predictors, sex
and history of eczema/hay fever, were highly
unlikely to have a relationship with the PAs
ðP40:2Þ:
Interaction assessments revealed that there were
multicollinearities between the eligible predictors
entered for the multivariate regression analysis
(Table 3). The TI and JS had a significant direct
association. The proportion of the South Asians
amongst patients with a higher TI (more depriva-
tion) and a higher JS (registered with a high-
workload GP) was significantly high. Also, there was
an inverse significant interaction between allergy
status and TI as well as allergy status and JS. In
addition, most of the patients with a history of
allergy were from the Non-South Asian (mainly
Caucasian) group.
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Table 1 Demographic and medical history of asthmatic patients.
Age (mean7SD) (range) 27.8720.4 (6–85 yrs)
Sex
Male 47 (40.9%)
Female 68 (67.8%)
Ethnicity
South Asians 37 (32.2%)
Non-South Asians (mainly Caucasians) 78 (67.8%)
Jarman score*
Patients registered in high-workload GPs 60 (52.2%)
Patients registered in low-workload GPs 48 (41.7%)
Unknown 7 (6.1%)
Townsend indexy
Patients living in the deprived areas 57 (49.6%)
Patients living in the affluent areas 51 (44.3%)
Unknown 7 (6.1%)
Allergy
Yes 54 (47.0%)
No 61 (53.0%)
History of eczema/hay fever
Yes 39 (33.9%)
No 76 (66.1%)
Home visits/month (mean7SD: 0.0770.33)
With home visits 37 (32.2%)
Without home visits 75 (65.2%)
Unknown 3 (2.6%)
Prednisolone rescue courses/year (mean7SD: 0.8171.41)
With prednisolone rescue courses 57 (49.6%)
Without prednisolone rescue courses 54 (47.0%)
Unknown 4 (3.4%)
Practice appointments/month (mean7SD) 1.0170.70
Preventive to reliever (P:R) ratio (mean7SD) 0.9670.94
*Divided based on the median ¼ 20.23.
yDivided based on the median ¼ 1.99.
Table 2 Results of the preliminary analyses used
to determine the predictors associated with the
square root of the practice appointments (OPA).
Predictor P value (r*)
Age 0.006 (r ¼ 0.27)
Sex 0.24
Ethnicity 0.10
Allergy 0.13
Eczema/hay fever 0.47
Townsend index 0.05
Jarman score 0.13
Number of HVs/month 0.95 (r ¼ 0.007)
Number of PRCs/year o0.0001 (r ¼ 0.36)
HVs—home visits; PRCs—prednisolone rescue courses.
*Correlation coefficients if applicable.
Table 3 Significant interactions between those
predictors eligible to be included in the multi-
variate ridge regression analysis.
Interaction P value
TI and JS o0.0001
TI and ethnicity o0.0001
TI and allergy status 0.037
JS and ethnicity o0.0001
JS and allergy status 0.008
Ethnicity and allergy status o0.0001
TI—Townsend Index; JS—Jarman Score.
J. Salamzadeh et al.738The six predictors of JS, TI, age, ethnicity,
allergy status, the number of HVs/month and the
number of PRCs/year together with their eligible
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regression analysis where the square root (O) of the
PAs/month was the outcome variable. This analysis
led to a model (P ¼ 0:002; r ¼ 0:46) in which
number of the PRCs/year and age could remain as
the significant predictors as follows:
PA ¼ ½0:70þ ð0:06 PRCsÞ þ ð0:003 AgeÞ	2:
This equation shows that patients with higher
number of the PRCs as well as elderly asthmatics
could have a higher PA rate.
P:R ratio
The mean (SD) and the median (interquartile range)
of the DDDs of the preventers were 207.26 (224.59)
and 125.55 (67.94, 334.47), respectively, and for
the relievers were 386.29 (478.53) and 214.29
(69.21, 498.47).
The results of the preliminary analyses to
identify the possible predictors for the log P:R are
presented in Table 4. This table shows that only the
number of PRCs/year could have a significant
negative association with the log P:R (P ¼ 0.04).
This means that patients with a higher number of
PRCs had a low P:R ratio and hence a low quality of
asthma prescribing. Also, there was a non-signifi-
cant direct relationship between the number of HVs
per month (HVs) and the log P:R (P ¼ 0:2). This
borderline P value allowed this predictor to be
included in the final multiple regression analysis.
Interaction evaluation revealed that there was no
significant interaction between the number of PRCs
and HVs. From the multivariate regression analysis,
only the number of PRCs could remain in the
model (P ¼ 0.04, r ¼ 0.21). This model could beTable 4 Results of the preliminary analyses for
the possible predictors of the log P:R ratio.
Predictor P value (r*)
Age 0.81 (r ¼ 0.02)
Sex 0.34
Ethnicity 0.26
Allergy 0.64
Eczema/hay fever 0.26
Townsend index 0.77
Jarman score 0.96
Number of PAs/month 0.96 (r ¼ 0.005)
Number of HVs/month 0.20 (r ¼ 0.13)
Number of PRCs/year 0.04 (r ¼ 0.20)
HVs—home visits; PA—practice appointments;
PRCs—prednisolone rescue courses.
*Correlation coefficients if applicable.written as
P : R ratio ¼ antilogð0:143 0:06PRCsÞ:
This equation shows that patients with a larger
number of PRCs per year would have a low P:R ratio
or a low quality of asthma prescribing.
To find out if either the preventer (numerator) or
reliever (denominator) mainly affects this relation-
ship, the association between these variables and
PRCs was assessed separately. For this determina-
tion, the Pearson correlation analysis was used.
Interestingly, the results revealed that there was a
direct significant correlation between the log of the
DDDs of relievers prescribed and the number of
PRCs (P ¼ 0.005, r ¼ 0.27). However, no significant
relationship was found between the number of
DDDs of preventers and PRCs (P ¼ 0.18, r ¼ 0.13).
Therefore, it could be suggested that patients
with more PRCs had been prescribed/used more
relievers but not more preventers.Discussion
Data analyses have revealed that PAs for high-risk
asthmatic patients could be directly related to the
number of short courses of oral prednisolone and
age. In other words, frequent oral steroid users and
elderly asthmatic patients could use the primary
care services more. Patients prescribed more short
courses of oral prednisolone had a lower ratio for
prescribed preventers to relievers (hence lower
quality of asthma prescribing). Furthermore, the
additional investigations of this relationship have
uncovered that this low quality of asthma prescrib-
ing was mainly correlated with higher reliever
prescribing. Such a correlation was not observed
for preventer prescribing. The high rates of reliever
usage could be an indirect indicator of the severity
of asthma and frequent asthma attack episodes.
Similarly, frequent PRCs could be a reflection of the
worsening symptom and/or unstable asthma. Sur-
prisingly, these frequent asthma attacks and
exacerbation episodes had not led to an increase
in prophylactic prescribing of inhaled steroids. It
seems that GPs and/or patients tended to control
the asthma worsening episodes by prescribing more
bronchodilators rather than prophylactic anti-in-
flammatory inhalers which are recommended as the
mainstay of asthma management.31 This confirms
the previous reports that a high number of oral
steroid courses could be a sign of poor prophylactic
asthma management.32 Our findings are in accor-
dance with other studies that have reported an
association between oral steroid use with asthma
hospitalisation33,34 and asthma morbidity.35–37
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by patients with frequent oral steroid usage are
lacking.
It should be contemplated that all patients
studied in this investigation were from a high-risk
group of asthmatics with a history of at least one
hospitalisation. Therefore, in the interpretation
of these findings and comparing with results
obtained by other investigations, this should be
acknowledged as a source of disagreement.Conclusion
This study has revealed that asthmatic patients
with frequent oral steroid use could have a higher
primary care utilisation, confirmed by a higher
number of PAs, and a low quality of asthma
prescribing. Elderly asthmatic patients could also
have higher rates of practice attendance. These
could probably be due to more severe asthma and
over-reliance on bronchodilators in frequent oral
steroid users as well as age-related difficulties
in elderly asthmatics. These results unveil the
importance of rational asthma management in
the primary care sector.Acknowledgement
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